Richert, Laura <br/><br/>
Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?  [electronic resource] 

 -  AIDS (London, England)  May 2013 
 - 1362-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e328360d52e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Clinical Trials as Topic<br/>HIV Infections--immunology<br/>HIV-1--immunology<br/>Humans<br/>Predictive Value of Tests<br/>Reproducibility of Results<br/>Viral Load